Study finds new use for rituximab in acute lymphoblastic leukaemia

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Immunotherapy makes patients’ tumours "melt away"

Quality assessment looking at rivaroxaban for cancer-related thrombosis

Tosedostat for elderly acute myeloid leukaemia

Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma

Daratumumab for multiple myeloma

Children most at risk of over-reporting adherence to at-home chemotherapy regimen

Cancer-associated thrombosis: Switching patients to warfarin after 6-month completion of anticoagulant treatment

Study suggests warfarin is acceptable for long-term treatment of cancer-associated thrombosis

Researchers identify children most at risk of over-reporting adherence to at-home chemotherapy regimen